BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
9/20/2026 4:00:02 AM | Browse: 4 | Download: 2
Publication Name World Journal of Virology
Manuscript ID 120124
Country Algeria
Received
2026-03-04 03:33
Peer-Review Started
2026-03-04 03:35
First Decision by Editorial Office Director
2026-04-16 08:15
Return for Revision
2026-04-16 08:15
Revised
2026-06-02 22:31
Publication Fee Transferred
Second Decision by Editor
2026-07-03 02:38
Second Decision by Editor-in-Chief
Final Decision by Editorial Office Director
2026-07-03 03:27
Articles in Press
2026-07-03 03:27
Edit the Manuscript by Language Editor
Typeset the Manuscript
2026-09-16 09:31
Publish the Manuscript Online
2026-09-20 04:00
ISSN 2220-3249 (online)
Open Access This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution-NonCommercial (CC BY-NC 4.0) license. No commercial re-use. See Permissions. Published by Baishideng Publishing Group Inc.
Copyright ©Author(s) (or their employer(s)) 2026. No commercial re-use. See Permissions. Published by Baishideng Publishing Group Inc.
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Gastroenterology & Hepatology
Manuscript Type Prospective Study
Article Title Discontinuation of nucleos(t)ide analog therapy in hepatitis B e antigen-negative non-cirrhotic chronic hepatitis B patients: A real-life study
Manuscript Source Invited Manuscript
All Author List Khellaf Amalou, Ryma Rekab, Nada Benmellouka, Boutheina Derbal, Ahlem Belloula, Hana Chetroub, Fadel Sabrina, Farid Belghanem and Khadidja Saidani
ORCID
Author(s) ORCID Number
Khellaf Amalou http://orcid.org/0000-0003-2626-0815
Funding Agency and Grant Number
Corresponding Author Khellaf Amalou, Assistant Professor, PhD, Department of Gastroenterology, Mohamed Seghir Nekkache, No. 246 Kouba, Algiers 16000, Algeria. amalou_kh@yahoo.fr
Key Words Hepatitis B; Treatment; Discontinuation; Relapse; Re-treatment
Core Tip Prolonged therapy remains the recommended method for patients with chronic hepatitis B. Nonetheless, concerns about treatment adherence and economic strain, particularly in resource-constrained areas, combined with research indicating that virological and clinical remission persists in non-cirrhotic patients after treatment cessation, prompted the development of nucleos(t)ide analog cessation guidelines for specific patients. However, the discontinuation of nucleos(t)ide analog is still a contested question. The median duration until recurrence was 11 months. The cumulative virological relapse rates, defined as chronic hepatitis B deoxyribonucleic acid over 2000 IU/mL, were 25%, 52%, 58%, and 61% at 6 months, 12 months, 24 months, and 36 months, respectively. The cumulative retreatment rates at 6 months, 12 months, 24 months, and 36 months were 19%, 25%, 28%, and 35%, respectively. Histologic fibrosis score > 2 is the unique factor for retreatment.
Publish Date 2026-09-20 04:00
Citation

Amalou K, Rekab R, Benmellouka N, Derbal B, Belloula A, Chetroub H, Sabrina F, Belghanem F, Saidani K. Discontinuation of nucleos(t)ide analog therapy in hepatitis B e antigen-negative non-cirrhotic chronic hepatitis B patients: A real-life study. World J Virol 2026; 15(3): 120124

URL https://www.wjgnet.com/2220-3249/full/v15/i3/120124.htm
DOI https://doi.org/10.5501/wjv.120124
Full Article (PDF) WJV-15-120124-with-cover.pdf
CONSORT 2010 Statement 120124-CONSORT-2010-statement.pdf
Manuscript File 120124_Auto_Edited_005103.docx
Answering Reviewers 120124-answering-reviewers.pdf
Audio Core Tip 120124-audio.m4a
Biostatistics Review Certificate 120124-biostatistics-statement.pdf
Clinical Trial Registration Statement 120124-clinical-trial-registration-statement.pdf
Conflict-of-Interest Disclosure Form 120124-conflict-of-interest-statement.pdf
Copyright License Agreement 120124-copyright-assignment.pdf
Signed Informed Consent Form(s) or Document(s) 120124-informed-consent-statement.pdf
Institutional Review Board Approval Form or Document 120124-institutional-review-board-statement.pdf
Non-Native Speakers of English Editing Certificate 120124-non-native-speakers.pdf
Peer-review Report 120124-peer-reviews.pdf
Scientific Misconduct Check 120124-scientific-misconduct-check.png
CrossCheck Report 120124-crosscheck-report.pdf